NL194373C - Werkwijze voor de bereiding van 3-hydroxy-ML-236B derivaten, bekend als M-4 en M-4'. - Google Patents
Werkwijze voor de bereiding van 3-hydroxy-ML-236B derivaten, bekend als M-4 en M-4'. Download PDFInfo
- Publication number
- NL194373C NL194373C NL8204505A NL8204505A NL194373C NL 194373 C NL194373 C NL 194373C NL 8204505 A NL8204505 A NL 8204505A NL 8204505 A NL8204505 A NL 8204505A NL 194373 C NL194373 C NL 194373C
- Authority
- NL
- Netherlands
- Prior art keywords
- nocardia
- ferm
- compound
- microorganism
- lactone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/365—Nocardia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/872—Nocardia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56186641A JPS5889191A (ja) | 1981-11-20 | 1981-11-20 | 3−ヒドロキシ−ml−236b誘導体の製造法 |
JP18664181 | 1981-11-20 |
Publications (3)
Publication Number | Publication Date |
---|---|
NL8204505A NL8204505A (nl) | 1983-06-16 |
NL194373B NL194373B (nl) | 2001-10-01 |
NL194373C true NL194373C (nl) | 2002-02-04 |
Family
ID=16192138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8204505A NL194373C (nl) | 1981-11-20 | 1982-11-19 | Werkwijze voor de bereiding van 3-hydroxy-ML-236B derivaten, bekend als M-4 en M-4'. |
Country Status (18)
Country | Link |
---|---|
US (1) | US4537859A (de) |
JP (1) | JPS5889191A (de) |
KR (1) | KR880002483B1 (de) |
AT (1) | AT387585B (de) |
AU (1) | AU551720B2 (de) |
BE (1) | BE895080A (de) |
CA (1) | CA1186647A (de) |
CH (1) | CH651065A5 (de) |
DE (1) | DE3242849A1 (de) |
DK (1) | DK159328C (de) |
ES (1) | ES517542A0 (de) |
FI (1) | FI70925C (de) |
FR (1) | FR2516935A1 (de) |
GB (1) | GB2111052B (de) |
IT (1) | IT1191235B (de) |
NL (1) | NL194373C (de) |
SE (1) | SE453996B (de) |
ZA (1) | ZA828535B (de) |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3682557D1 (de) * | 1985-09-13 | 1992-01-02 | Sankyo Co | Hydroxy-ml-236b-derivate, deren herstellung und anwendung. |
USRE36481E (en) * | 1986-06-23 | 2000-01-04 | Merck & Co., Inc. | HMG-CoA reductase inhibitors |
US5116870A (en) * | 1986-06-23 | 1992-05-26 | Merck & Co., Inc. | HMG-CoA reductase inhibitors |
US4940727A (en) * | 1986-06-23 | 1990-07-10 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
US4833258A (en) * | 1987-02-17 | 1989-05-23 | Merck & Co., Inc. | Intermediates useful in the preparation of HMG-COA reductase inhibitors |
EP0306263B1 (de) * | 1987-09-02 | 1992-03-18 | Merck & Co. Inc. | Inhibitoren von HMG-CoA-Reduktase |
US4997848A (en) | 1987-10-27 | 1991-03-05 | Sankyo Company, Limited | Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition |
EP0337548A3 (de) * | 1988-04-15 | 1991-08-14 | Merck & Co. Inc. | Inhibitoren von HMG-COA-Reduktase, hergestellt durch Nocardia SP.(MA6455)(ATCC 53695) |
US4997755A (en) * | 1988-04-15 | 1991-03-05 | Merck & Co., Inc. | HMG-CoA reductase inhibitors produced by Nocardia sp. (MA 6455) |
US4963538A (en) * | 1988-06-29 | 1990-10-16 | Merck & Co., Inc. | 5-oxygenated HMG-CoA reductase inhibitors |
US5010105A (en) * | 1989-06-09 | 1991-04-23 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
US5041562A (en) * | 1989-06-09 | 1991-08-20 | Merck & Co., Inc. | 3-keto HMG-CoA reductase inhibitors |
US5001241A (en) * | 1989-06-09 | 1991-03-19 | Merck & Co., Inc. | 3-KETO HMG-CoA reductase inhibitors |
US4970231A (en) * | 1989-06-09 | 1990-11-13 | Merck & Co., Inc. | 4-substituted HMG-CoA reductase inhibitors |
US4937259A (en) * | 1989-06-09 | 1990-06-26 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
US4965200A (en) * | 1989-06-23 | 1990-10-23 | Merck & Co., Inc. | Process for the preparation of 3-keto, 5-hydroxy simvastatin analogs |
US4997849A (en) * | 1989-06-23 | 1991-03-05 | Merck & Co., Inc. | Microbial transformation of simvastatin |
US5112857A (en) * | 1990-09-04 | 1992-05-12 | Merck & Co., Inc. | Hmg-coa reductase inhibitor metabolites |
NZ250609A (en) * | 1992-12-28 | 1995-07-26 | Sankyo Co | Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments |
US6043064A (en) * | 1993-10-22 | 2000-03-28 | Bristol-Myers Squibb Company | Enzymatic hydroxylation process for the preparation of HMG-CoA reductase inhibitors and intermediates thereof |
US5942423A (en) * | 1995-06-07 | 1999-08-24 | Massachusetts Institute Of Technology | Conversion of compactin to pravastatin by actinomadura |
SI9800144A (sl) * | 1998-05-21 | 1999-12-31 | LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. | Nov biotehnološki postopek pridobivanja 3-hidroksi-ML-236B derivatov poznanih kot M-4 in M-4' |
SI20305A (sl) * | 1999-08-06 | 2001-02-28 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Kristali natrijeve soli pravastatina |
CN1240844C (zh) * | 1999-01-20 | 2006-02-08 | 协和发酵工业株式会社 | HMG-CoA还原酶抑制剂的制备方法 |
US7049111B1 (en) * | 1999-01-29 | 2006-05-23 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing HMG-CoA reductase inhibitor |
US6682913B1 (en) * | 1999-02-03 | 2004-01-27 | Institute For Drug Research Ltd. | Microbial process for preparing pravastatin |
HUP9902352A1 (hu) | 1999-07-12 | 2000-09-28 | Gyógyszerkutató Intézet Kft. | Eljárás pravasztatin mikrobiológiai előállítására |
CA2422744A1 (en) * | 2000-10-05 | 2002-04-18 | Biogal Gyogyszergyar Rt. | Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same |
JP3236282B1 (ja) * | 2000-10-16 | 2001-12-10 | 三共株式会社 | プラバスタチンを精製する方法 |
JP2003093045A (ja) * | 2001-09-26 | 2003-04-02 | Godo Shusei Co Ltd | 有用変換微生物 |
US20050113577A1 (en) * | 2002-04-16 | 2005-05-26 | Karki Shyam B. | Solid forms of slats with tyrosine kinase activity |
US20040198800A1 (en) * | 2002-12-19 | 2004-10-07 | Geoffrey Allan | Lipoxygenase inhibitors as hypolipidemic and anti-hypertensive agents |
ATE407670T1 (de) | 2002-12-20 | 2008-09-15 | Pfizer Prod Inc | Dosierungsform enthaltend einen cetp-hemmer und einen hmg-coa reduktase hemmer |
US20040132771A1 (en) * | 2002-12-20 | 2004-07-08 | Pfizer Inc | Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors |
KR100470078B1 (ko) * | 2003-06-12 | 2005-02-04 | 씨제이 주식회사 | 컴팩틴을 프라바스타틴으로 전환할 수 있는 스트렙토마이세스 종(Streptomyces sp.)CJPV 975652 및 그를 이용한 프라바스타틴의 제조방법 |
AU2004266740B2 (en) | 2003-08-21 | 2010-08-26 | Merck Frosst Canada Ltd | Cathepsin cysteine protease inhibitors |
US20050101927A1 (en) * | 2003-09-11 | 2005-05-12 | Kimberly-Clark Worldwide, Inc. | Absorbent products comprising a moisturizing and lubricating composition |
KR20060109926A (ko) | 2003-11-19 | 2006-10-23 | 메타베이시스 테라퓨틱스, 인크. | 새로운 인-함유 갑상선 호르몬 모방약들 |
TWI252253B (en) * | 2004-01-09 | 2006-04-01 | Chinese Petroleum Corp | A novel Pseudonocardia sp RMRC PAH4 and a process for bioconverting compactin into pravastatin using the same |
KR100637762B1 (ko) * | 2004-07-30 | 2006-10-23 | 주식회사 지니스 | 저콜레스테롤 란을 생산하기 위한 가금류용 사료첨가제 및 이를 이용한 저콜레스테롤 란의 생산방법 |
US20110217412A1 (en) * | 2004-07-30 | 2011-09-08 | Jinis Biopharmaceuticals Co. | Cholesterol lowering supplement and low cholesterol egg produced by using the same |
TWI307360B (en) | 2004-12-03 | 2009-03-11 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Process for constructing strain having compactin hydroxylation ability |
RU2394820C2 (ru) | 2004-12-09 | 2010-07-20 | Мерк Шарп Энд Домэ Корп. | Модуляторы рецептора эстрогена |
DK1855674T3 (da) | 2005-03-02 | 2014-10-20 | Merck Sharp & Dohme | Sammensætning til hæmning af cathepsin k |
US8362075B2 (en) | 2005-05-17 | 2013-01-29 | Merck Sharp & Dohme Corp. | Cyclohexyl sulphones for treatment of cancer |
TW200804345A (en) * | 2005-08-30 | 2008-01-16 | Novartis Ag | Substituted benzimidazoles and methods of preparation |
GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
PL2010528T3 (pl) | 2006-04-19 | 2018-03-30 | Novartis Ag | 6-0-podstawione związki benzoksazolowe i benzotiazolowe i sposoby hamowania sygnalizacji csf-1r |
EP2083831B1 (de) | 2006-09-22 | 2013-12-25 | Merck Sharp & Dohme Corp. | Verfahren zur behandlung von fettsäure-synthese-hemmern |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
SI2805945T1 (sl) | 2007-01-10 | 2019-09-30 | Msd Italia S.R.L. | Amid substituirani indazoli, kot inhibitorji poli(ADP-riboza)polimeraze(PARP) |
EP2132177B1 (de) | 2007-03-01 | 2013-07-17 | Novartis AG | Pim-kinase-hemmer und verfahren zu ihrer verwendung |
KR20100017866A (ko) | 2007-05-21 | 2010-02-16 | 노파르티스 아게 | Csf-1r 억제제, 조성물 및 사용 방법 |
CA2690191C (en) | 2007-06-27 | 2015-07-28 | Merck Sharp & Dohme Corp. | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
WO2009082437A2 (en) | 2007-12-21 | 2009-07-02 | Ligand Pharmaceuticals Incorporated | Selective androgen receptor modulators (sarms) and uses thereof |
JP5616328B2 (ja) * | 2008-04-25 | 2014-10-29 | 株式会社アモーレパシフィックAmorepacific Corporation | 生体内変換システムを利用したオルソ−ジヒドロキシイソフラボンの製造方法 |
US20120046364A1 (en) | 2009-02-10 | 2012-02-23 | Metabasis Therapeutics, Inc. | Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use |
EP2413932A4 (de) | 2009-04-01 | 2012-09-19 | Merck Sharp & Dohme | Hemmer der akt-aktivität |
CA2777043C (en) | 2009-10-14 | 2015-12-15 | Schering Corporation | Substituted piperidines that increase p53 activity and the uses thereof |
US8999957B2 (en) | 2010-06-24 | 2015-04-07 | Merck Sharp & Dohme Corp. | Heterocyclic compounds as ERK inhibitors |
US8518907B2 (en) | 2010-08-02 | 2013-08-27 | Merck Sharp & Dohme Corp. | RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) |
EP2606134B1 (de) | 2010-08-17 | 2019-04-10 | Sirna Therapeutics, Inc. | Rna-interferenz-vermittelte hemmung der hepatitis b-virus (hbv)-genexpression mittels kurzer interferierender nukleinsäure (sina) |
US8883801B2 (en) | 2010-08-23 | 2014-11-11 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors |
WO2012030685A2 (en) | 2010-09-01 | 2012-03-08 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
WO2012036997A1 (en) | 2010-09-16 | 2012-03-22 | Schering Corporation | Fused pyrazole derivatives as novel erk inhibitors |
EP3766975A1 (de) | 2010-10-29 | 2021-01-20 | Sirna Therapeutics, Inc. | Rna-interferenz-vermittelte inhibition von genexpression unter verwendung kurzer interferierender nukleinsäure (sina) |
US9351965B2 (en) | 2010-12-21 | 2016-05-31 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as ERK inhibitors |
US8791162B2 (en) | 2011-02-14 | 2014-07-29 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
WO2012143879A1 (en) | 2011-04-21 | 2012-10-26 | Piramal Healthcare Limited | A crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation |
EP2770987B1 (de) | 2011-10-27 | 2018-04-04 | Merck Sharp & Dohme Corp. | Neue verbindungen als erk-hemmer |
WO2013165816A2 (en) | 2012-05-02 | 2013-11-07 | Merck Sharp & Dohme Corp. | SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS |
AU2013323508B2 (en) | 2012-09-28 | 2017-11-02 | Merck Sharp & Dohme Corp. | Novel compounds that are ERK inhibitors |
ES2651347T3 (es) | 2012-11-28 | 2018-01-25 | Merck Sharp & Dohme Corp. | Composiciones y métodos para el tratamiento del cáncer |
CA2895504A1 (en) | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as hdm2 inhibitors |
US9540377B2 (en) | 2013-01-30 | 2017-01-10 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as HDM2 inhibitors |
US20160194368A1 (en) | 2013-09-03 | 2016-07-07 | Moderna Therapeutics, Inc. | Circular polynucleotides |
CA2923272A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
WO2015051479A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
EP3094323A4 (de) | 2014-01-17 | 2017-10-11 | Ligand Pharmaceuticals Incorporated | Verfahren und zusammensetzungen zur modulierung von hormonspiegeln |
WO2015120580A1 (en) | 2014-02-11 | 2015-08-20 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
JO3589B1 (ar) | 2014-08-06 | 2020-07-05 | Novartis Ag | مثبطات كيناز البروتين c وطرق استخداماتها |
EP3525785A4 (de) | 2016-10-12 | 2020-03-25 | Merck Sharp & Dohme Corp. | Kdm5-inhibitoren |
WO2019094311A1 (en) | 2017-11-08 | 2019-05-16 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
EP3833667B1 (de) | 2018-08-07 | 2024-03-13 | Merck Sharp & Dohme LLC | Prmt5-inhibitoren |
WO2020033282A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
WO2021126731A1 (en) | 2019-12-17 | 2021-06-24 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
WO2024180169A1 (en) | 2023-03-02 | 2024-09-06 | Carcimun Biotech Gmbh | Means and methods for diagnosing cancer and/or an acute inflammatory disease |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3281330A (en) * | 1964-03-20 | 1966-10-25 | Upjohn Co | Microbiological process for the oxygenation of cycloalkanes |
US3392171A (en) * | 1964-03-20 | 1968-07-09 | Upjohn Co | 4-morpholino-4'-hydroxy bicyclohexyls |
DK149080C (da) * | 1980-06-06 | 1986-07-28 | Sankyo Co | Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre |
-
1981
- 1981-11-20 JP JP56186641A patent/JPS5889191A/ja active Granted
-
1982
- 1982-11-16 CA CA000415650A patent/CA1186647A/en not_active Expired
- 1982-11-16 AU AU90610/82A patent/AU551720B2/en not_active Expired
- 1982-11-18 SE SE8206580A patent/SE453996B/sv not_active IP Right Cessation
- 1982-11-18 US US06/442,840 patent/US4537859A/en not_active Expired - Lifetime
- 1982-11-19 FR FR8219433A patent/FR2516935A1/fr active Granted
- 1982-11-19 CH CH6754/82A patent/CH651065A5/de not_active IP Right Cessation
- 1982-11-19 NL NL8204505A patent/NL194373C/nl not_active IP Right Cessation
- 1982-11-19 ZA ZA828535A patent/ZA828535B/xx unknown
- 1982-11-19 FI FI823978A patent/FI70925C/fi not_active IP Right Cessation
- 1982-11-19 DK DK516182A patent/DK159328C/da not_active IP Right Cessation
- 1982-11-19 DE DE19823242849 patent/DE3242849A1/de active Granted
- 1982-11-19 BE BE0/209527A patent/BE895080A/fr unknown
- 1982-11-19 ES ES517542A patent/ES517542A0/es active Granted
- 1982-11-20 KR KR8205250A patent/KR880002483B1/ko active
- 1982-11-22 AT AT0425182A patent/AT387585B/de not_active IP Right Cessation
- 1982-11-22 IT IT68359/82A patent/IT1191235B/it active Protection Beyond IP Right Term
- 1982-11-22 GB GB08233267A patent/GB2111052B/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FI823978L (fi) | 1983-05-21 |
ES8402350A1 (es) | 1984-01-16 |
SE8206580D0 (sv) | 1982-11-18 |
IT1191235B (it) | 1988-02-24 |
KR880002483B1 (ko) | 1988-11-19 |
DE3242849C2 (de) | 1989-01-05 |
CA1186647A (en) | 1985-05-07 |
DK516182A (da) | 1983-05-21 |
US4537859A (en) | 1985-08-27 |
ZA828535B (en) | 1983-10-26 |
SE8206580L (sv) | 1983-05-21 |
NL194373B (nl) | 2001-10-01 |
DK159328B (da) | 1990-10-01 |
BE895080A (fr) | 1983-03-16 |
FR2516935A1 (fr) | 1983-05-27 |
DE3242849A1 (de) | 1983-06-01 |
GB2111052B (en) | 1985-05-09 |
KR840002451A (ko) | 1984-07-02 |
CH651065A5 (de) | 1985-08-30 |
IT8268359A0 (it) | 1982-11-22 |
JPH0371116B2 (de) | 1991-11-12 |
JPS5889191A (ja) | 1983-05-27 |
SE453996B (sv) | 1988-03-21 |
FI70925B (fi) | 1986-07-18 |
FI70925C (fi) | 1986-10-27 |
AU551720B2 (en) | 1986-05-08 |
NL8204505A (nl) | 1983-06-16 |
FR2516935B1 (de) | 1985-02-08 |
GB2111052A (en) | 1983-06-29 |
AU9061082A (en) | 1983-05-26 |
DK159328C (da) | 1991-02-25 |
ATA425182A (de) | 1988-07-15 |
ES517542A0 (es) | 1984-01-16 |
AT387585B (de) | 1989-02-10 |
FI823978A0 (fi) | 1982-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL194373C (nl) | Werkwijze voor de bereiding van 3-hydroxy-ML-236B derivaten, bekend als M-4 en M-4'. | |
IE921801A1 (en) | Fermentation of a triol heptanoic acid by mutant strains of aspergillus terreus | |
RU2235780C2 (ru) | Гидроксилирование компактина до правастатина с помощью micromonospora | |
US5153124A (en) | Hydroxyl-ml-236b derivatives, their preparation and use | |
JP3854866B2 (ja) | ミコフェノール酸およびその誘導体の製造方法 | |
Ohno et al. | Isolation and characterization of elasnin, a new human granulocyte elastase inhibitor produced by a strain of Streptomyces | |
US4965200A (en) | Process for the preparation of 3-keto, 5-hydroxy simvastatin analogs | |
US4228239A (en) | Method for producing antibiotic C-15003 P-3 | |
US5169778A (en) | Amycolatopsis trehalostatica strain | |
US4997755A (en) | HMG-CoA reductase inhibitors produced by Nocardia sp. (MA 6455) | |
US4229533A (en) | Method for producing antibiotic C-15003 P-4 | |
US4351769A (en) | Antibiotic composition of matter | |
CA2009043A1 (en) | Process for the preparation of 6-alpha-hydroxymethyl lovastatin derivatives | |
US5109133A (en) | Antibiotic trienomycins and their production | |
HU202284B (en) | Process for producing new azoxy derivatives and pharmaceutical compositions comprising same as active ingredient | |
US5272174A (en) | Hydroxy-ML-236B derivatives, their preparation and use | |
FI70595C (fi) | Framstaellningsfoerfarande foer narasin | |
EP0337548A3 (de) | Inhibitoren von HMG-COA-Reduktase, hergestellt durch Nocardia SP.(MA6455)(ATCC 53695) | |
JPH0538283A (ja) | 新規微生物 | |
AU2004200673A1 (en) | Process for the preparation of mycophenolic acid and derivatives thereof | |
AU2004201294A1 (en) | Process for the preparation of mycophenolic acid and derivatives thereof | |
JPH0482135B2 (de) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
A85 | Still pending on 85-01-01 | ||
BC | A request for examination has been filed | ||
V4 | Discontinued because of reaching the maximum lifetime of a patent |
Effective date: 20021119 |